Maria Concetta La Milia: Patient-Reported Outcomes in Nose Vestibule Interventional Radiotherapy at ESTRO2025
Maria Concetta La Milia, Resident Physician in Radiation Oncology at the Agostino Gemelli University Hospital Foundation (IRCCS), shared a post on LinkedIn:
“Thrilled to present our latest study PRO-NOVELTY: Patient-Reported Outcomes in Nose Vestibule Interventional Radiotherapy (Brachytherapy) – An Update, at ESTRO2025, organized by the European Society for Radiotherapy and Oncology (ESTRO).
IRT proves to be an effective and functionally sparing treatment alternative, reinforcing its role in modern head and neck oncology.
This study also underlines the value of PROs in guiding patient-centered care.
Proud of the incredible team behind this work. Link.”
Maria Concetta La Milia shared the PRO-NOVELTY study update, which highlights patient-reported outcomes in nose vestibule interventional radiotherapy. Presented at ESTRO2025, the research supports brachytherapy as a function-preserving option in head and neck cancer care.
More posts featuring ESTRO2025 on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023